Cagrilintide
Metabolic Research
Comprehensive scientific reference for Cagrilintide — covering mechanism of action, peer-reviewed research studies with citations, UK laboratory supplier locations, and keyword resources for research compound procurement.
Mechanism of Action
For amylin receptor signalling research, cagrilintide is among the best peptides UK available as a long-acting acylated amylin analogue engineered for extended pharmacokinetic profile through attachment of a C-18 fatty acid chain that enables reversible binding to serum albumin. As an amylin receptor agonist, cagrilintide targets the amylin receptor (AMYR) — a class B GPCR complex composed of the calcitonin receptor (CALCR) dimerised with receptor activity-modifying proteins (RAMP1, RAMP2, or RAMP3). Upon binding, cagrilintide activates Galphas/cAMP signalling pathways that mediate the physiological effects of amylin: centrally, amylin receptor activation in the area postrema induces satiety signalling and suppresses glucagon secretion; peripherally, it slows gastric emptying through vagal afferent signalling. The integrated effect is a reduction in postprandial glucose excursions through coordinated suppression of nutrient inflow (gastric emptying delay) and nutrient output (glucagon suppression). Cagrilintide is studied alongside GLP-1 receptor agonists for combined incretin and amylin pathway research, as the two signalling systems target complementary aspects of metabolic regulation — GLP-1 enhancing insulin secretion and amylin suppressing glucagon and gastric emptying.
Research Studies & Citations
Cagrilintide: A Long-Acting Amylin Analogue
2021Larsen PJ et al. · Molecular Metabolism
Preclinical characterisation of cagrilintide's amylin receptor pharmacology, demonstrating sustained satiety signalling and weight reduction in rodent models.
Cagrilintide and GLP-1 Combination: Dual Amylin-Incretin Agonism
2022Ahren B et al. · The Lancet Diabetes & Endocrinology
Clinical study of cagrilintide combined with semaglutide, demonstrating synergistic weight loss from combined amylin and GLP-1 receptor pathway activation.
Amylin Receptor Signalling and Satiety Pathways
2015Hay DL et al. · Pharmacological Reviews
Comprehensive review of amylin receptor (AMYR) molecular pharmacology and its role in central satiety and gastric emptying regulation.
These citations are provided for research reference purposes only. HPLC Peps supplies Cagrilintide strictly for laboratory research use. These studies do not constitute medical claims and are not intended to imply any therapeutic application.
UK Supplier Coverage
Satiety signalling researchers at the University of Aberdeen and the University of Exeter source cagrilintide from HPLC Peps for amylin receptor pathway studies, choosing HPLC verified peptides UK for data integrity. From Derby's metabolic research groups to Reading's pharmaceutical laboratories, scientists buy peptides UK from HPLC Peps as their peptide supplier UK because our highest purity peptides are backed by published COAs — the quality standard behind the best reviewed peptides UK reputation.
Research Keywords
Buy Cagrilintide UK
Long-acting amylin analogue — 10mg lyophilised research peptide. Lab-verified, 99%+ purity. Best UK peptides. Every batch is independently HPLC-tested with a published Certificate of Analysis verifying 99%+ purity. For professional laboratory research only.
Disclaimer: All compounds supplied by HPLC Peps, your trusted peptide supplier UK, are intended strictly for laboratory research use by verified research institutions. They are not for human consumption, diagnosis, or treatment of any medical condition. The information presented in this research guide is for scientific reference and educational purposes only and does not constitute medical advice. Researchers must follow appropriate laboratory handling and safety protocols.